Cardiac amyloidosis is irreversible thickening of the heart muscle that typically presents as a form of congestive heart failure. It is overlooked often because the symptoms can masquerade as other conditions. Unfortunately, there aren’t any preventive strategies for cardiac amyloidosis, says Dr. Melissa Lyle, a Mayo Clinic cardiologist.
“So the key, really, is early detection,” says Dr. Lyle. “We want to make sure that we can detect these patients earlier, to get them on the right treatments.”
She says it’s important that patients bring any concerning symptoms to their health care provide, as soon as possible.
In this Mayo Clinic Q&A podcast, Dr. Lyle explains what those symptoms might be and talks about new therapies for treating cardiac amyloidosis.
Read the full transcript.
For the safety of its patients, staff and visitors, Mayo Clinic has strict masking policies in place. Anyone shown without a mask was either recorded prior to COVID-19 or recorded in a nonpatient care area where social distancing and other safety protocols were followed.